Tvardi Therapeutics Inc.
TVRD | NASDAQ
$1.69
+$0.08 (+4.97%)
Sep 22, 2026, 2:35 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 2.57M | n/a | n/a | n/a | 2.14M | 3M | 4.87M |
Cost of Revenue | n/a | n/a | n/a | n/a | 47K | n/a | n/a | n/a | 5K | 620K | 690K | 1.62M |
Gross Profit | n/a | n/a | n/a | n/a | -47K | 2.57M | n/a | n/a | -5K | 1.52M | 2.31M | 3.25M |
Operating Income | -6.63M | -7.05M | -7.59M | -5.94M | -8.87M | -2.39M | -10.8M | -5.68M | -7.18M | -29.67M | -32.61M | -28.9M |
Interest Income | 172K | 247K | 312K | 411K | 377K | n/a | 421K | 766K | 206K | n/a | 313K | 866K |
Pretax Income | -6.46M | -6.8M | -7.28M | -5.53M | 4.17M | -4.91M | -12.71M | -5.51M | -6.98M | -30.7M | -32.34M | -28.03M |
Net Income | -6.46M | -6.8M | -7.28M | -5.53M | 4.17M | -4.91M | -12.71M | -5.51M | -6.98M | -30.7M | -32.34M | -28.03M |
Selling & General & Admin | 2.63M | 2.14M | 2.1M | 2.34M | 3.06M | 4.64M | 2.2M | 881K | 645K | 6.79M | 6.55M | 6.72M |
Research & Development | 4M | 4.91M | 5.49M | 3.6M | 5.81M | 319K | 8.6M | 4.8M | 6.53M | 21.96M | 28.37M | 25.42M |
Other Expenses | n/a | n/a | n/a | n/a | -47K | n/a | n/a | n/a | n/a | 2.43M | n/a | n/a |
Operating Expenses | 6.63M | 7.05M | 7.59M | 5.94M | 8.82M | 4.96M | 10.8M | 5.68M | 7.18M | 31.18M | 34.92M | 32.15M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 2.87M | 2.62M | 1.96M | 1.91M | 1.98M | n/a | n/a |
Selling & Marketing Expenses | n/a | 46K | 46K | 45K | n/a | n/a | 50K | 43K | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.63M | 7.05M | 7.59M | 5.94M | 8.87M | 4.96M | 10.8M | 5.68M | 7.18M | 31.8M | 35.61M | 33.76M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 9.36M | 9.38M | 9.33M | 9.38M | 8.25M | 9.36M | 1.52M | 1.52M | 1.52M | 9.36M | 9.36M | 1.51M |
Shares Outstanding (Diluted) | 9.38M | 9.38M | 9.38M | 9.38M | 8.46M | 9.36M | 1.52M | 1.52M | 1.52M | 9.36M | 9.36M | 1.51M |
EPS (Basic) | -0.69 | -0.73 | -0.78 | -0.59 | 0.51 | -0.52 | -5.04 | -8.19 | -13.17 | -3.28 | -0.46 | -18.61 |
EPS (Diluted) | -0.69 | -0.73 | -0.78 | -0.59 | -1 | -0.52 | -5.04 | -8.19 | -13.17 | -3.28 | -0.46 | -18.61 |
EBITDA | -6.61M | -6.8M | -7.25M | -5.5M | 4.21M | -2.02M | -10.06M | -3.53M | -6.97M | -28.67M | -31.65M | -27.51M |
EBIT | -6.63M | -6.8M | -7.28M | -5.53M | 4.17M | -2.04M | -10.09M | -3.55M | -6.98M | -28.71M | -31.73M | -28.03M |
Depreciation & Amortization | 23K | n/a | 24K | 24K | 47K | 24K | 24K | 24K | 5K | 42K | 82K | 521K |
Add to Watchlist
Select watchlists to add or remove TVRD